BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 38331373)

  • 41. Methylation estimates the risk of precancer in HPV-infected women with discrepant results between cytology and HPV16/18 genotyping.
    Hernández-López R; Lorincz AT; Torres-Ibarra L; Reuter C; Scibior-Bentkowska D; Warman R; Nedjai B; Mendiola-Pastrana I; León-Maldonado L; Rivera-Paredez B; Ramírez-Palacios P; Lazcano-Ponce E; Cuzick J; Salmerón J;
    Clin Epigenetics; 2019 Oct; 11(1):140. PubMed ID: 31606044
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Integrating CRISPR-Cas12a into a Microfluidic Dual-Droplet Device Enables Simultaneous Detection of HPV16 and HPV18.
    Zhao Y; Chen D; Xu Z; Li T; Zhu J; Hu R; Xu G; Li Y; Yang Y; Liu M
    Anal Chem; 2023 Feb; 95(6):3476-3485. PubMed ID: 36724385
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Development and characterization of the cobas human papillomavirus test.
    Rao A; Young S; Erlich H; Boyle S; Krevolin M; Sun R; Apple R; Behrens C
    J Clin Microbiol; 2013 May; 51(5):1478-84. PubMed ID: 23447640
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Development and validation of real-time recombinase polymerase amplification-based assays for detecting HPV16 and HPV18 DNA.
    Ying J; Mao L; Tang Y; Fassatoui M; Song W; Xu X; Tang X; Li J; Liu H; Jian F; Du Q; Wong G; Feng W; Berthet N
    Microbiol Spectr; 2023 Dec; 11(6):e0120723. PubMed ID: 37787547
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Assessment of clinical performance of an ultrasensitive nanowire assay for detecting human papillomavirus DNA in urine.
    Lee H; Choi M; Jo M; Park EY; Hwang SH; Cho Y
    Gynecol Oncol; 2020 Mar; 156(3):641-646. PubMed ID: 31926639
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Colorimetric detection of HPV6 and HPV16 by loop mediated isothermal amplification].
    Lu CB; Luo L; Yang MJ; Nie K; Wang M; Ma XJ
    Bing Du Xue Bao; 2011 Jan; 27(1):64-70. PubMed ID: 21462508
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Genomagnetic LAMP-based electrochemical test for determination of high-risk HPV16 and HPV18 in clinical samples.
    Bartosik M; Jirakova L; Anton M; Vojtesek B; Hrstka R
    Anal Chim Acta; 2018 Dec; 1042():37-43. PubMed ID: 30428986
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Electrochemical bioassay coupled to LAMP reaction for determination of high-risk HPV infection in crude lysates.
    Izadi N; Sebuyoya R; Moranova L; Hrstka R; Anton M; Bartosik M
    Anal Chim Acta; 2021 Dec; 1187():339145. PubMed ID: 34753575
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Rapid In Situ Hydrogel LAMP for On-Site Large-Scale Parallel Single-Cell HPV Detection.
    Wang J; Jing G; Huang W; Xin L; Du J; Cai X; Xu Y; Lu X; Chen W
    Anal Chem; 2022 Dec; 94(51):18083-18091. PubMed ID: 36517452
    [TBL] [Abstract][Full Text] [Related]  

  • 50. HPV33 DNA methylation measurement improves cervical pre-cancer risk estimation of an HPV16, HPV18, HPV31 and \textit{EPB41L3} methylation classifier.
    Brentnall AR; Vasiljevic N; Scibior-Bentkowska D; Cadman L; Austin J; Cuzick J; Lorincz AT
    Cancer Biomark; 2015; 15(5):669-75. PubMed ID: 26406956
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Method for the elucidation of LAMP products captured on lateral flow strips in a point of care test for HPV 16.
    Landaverde L; Wong W; Hernandez G; Fan A; Klapperich C
    Anal Bioanal Chem; 2020 Sep; 412(24):6199-6209. PubMed ID: 32488390
    [TBL] [Abstract][Full Text] [Related]  

  • 52. High-risk human papillomavirus detection in self-collected vaginal samples compared with healthcare worker collected cervical samples among women attending gynecology clinics at a tertiary hospital in Pretoria, South Africa.
    Tiiti TA; Mashishi TL; Nkwinika VV; Benoy I; Selabe SG; Bogers J; Lebelo RL
    Virol J; 2021 Sep; 18(1):192. PubMed ID: 34556128
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Diagnostic value of human papillomavirus (HPV) 16 and HPV18 viral loads for the detection of high-grade cervical intraepithelial neoplasia (CIN2+) in a cohort of African women living with HIV.
    Segondy M; Ngou J; Kelly H; Omar T; Goumbri-Lompo O; Doutre S; Mayaud P; Didelot MN
    J Clin Virol; 2018; 99-100():79-83. PubMed ID: 29353074
    [TBL] [Abstract][Full Text] [Related]  

  • 54. A novel human papillomavirus and host DNA methylation score and detection of cervical adenocarcinoma.
    Gradissimo A; Clarke MA; Xue X; Castle PE; Raine-Bennett TR; Schiffman M; Wentzensen N; Strickler HD; Burk RD
    J Natl Cancer Inst; 2023 Dec; 115(12):1535-1543. PubMed ID: 37467068
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Performance of human papillomavirus typing test in cervical precancer lesions and cervical cancer screening].
    Zhang SK; Luo XP; Li ZF; Su Z; Xia JC; Hu GY; Zhu YJ; Xie LX; Feng XX; Sun XB; Chen W; Qiao YL
    Zhonghua Zhong Liu Za Zhi; 2020 Mar; 42(3):252-256. PubMed ID: 32252206
    [No Abstract]   [Full Text] [Related]  

  • 56. Risk stratification for cervical neoplasia using extended high-risk HPV genotyping in women with ASC-US cytology: A large retrospective study from China.
    Tao X; Austin RM; Yu T; Zhong F; Zhou X; Cong Q; Sui L; Zhao C
    Cancer Cytopathol; 2022 Apr; 130(4):248-258. PubMed ID: 34874615
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Increase in viral load, viral integration, and gain of telomerase genes during uterine cervical carcinogenesis can be simultaneously assessed by the HPV 16/18 MLPA-assay.
    Theelen W; Speel EJ; Herfs M; Reijans M; Simons G; Meulemans EV; Baldewijns MM; Ramaekers FC; Somja J; Delvenne P; Hopman AH
    Am J Pathol; 2010 Oct; 177(4):2022-33. PubMed ID: 20813962
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Development of DNA Vaccine Targeting E6 and E7 Proteins of Human Papillomavirus 16 (HPV16) and HPV18 for Immunotherapy in Combination with Recombinant Vaccinia Boost and PD-1 Antibody.
    Peng S; Ferrall L; Gaillard S; Wang C; Chi WY; Huang CH; Roden RBS; Wu TC; Chang YN; Hung CF
    mBio; 2021 Jan; 12(1):. PubMed ID: 33468698
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Comparison of clinical performances among Roche Cobas HPV, RFMP HPV PapilloTyper and Hybrid Capture 2 assays for detection of high-risk types of human papillomavirus.
    Yu S; Kwon MJ; Lee EH; Park H; Woo HY
    J Med Virol; 2015 Sep; 87(9):1587-93. PubMed ID: 25914215
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Evaluation of a prototype real-time PCR assay for carcinogenic human papillomavirus (HPV) detection and simultaneous HPV genotype 16 (HPV16) and HPV18 genotyping.
    Castle PE; Sadorra M; Lau T; Aldrich C; Garcia FA; Kornegay J
    J Clin Microbiol; 2009 Oct; 47(10):3344-7. PubMed ID: 19675214
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.